The broad objective of this research is to determine the molecular basis of cataracts produced by inhibitors of lens cholesterol biosynthesis. Since development of the U18666A and human senile cataract both likely involve early damage to lens membrane and increased crystallin binding to this membrane, describing the mechanism of the U18666A cataract could contribute to improved understanding of human cataracts. The specific objective is to determine the mechanism by which changing lens membrane sterol composition leads to increased membrane association of crystallins and to protein insolubilization. The work is divided into four phases. 1. We will identify the specific soluble polypeptides which give rise to the insoluble protein that accumulates in the U18666A cataract and their spacial location in the lens at the time of insolubilization. Lens crystallins will be pulse labeled in vivo from 3H-leucine in rats before onset of treatment with U18666A. Label polypeptides will be identified by coupling flatbed isoelectric focusing with fluorography and immunoblotting. 2. The association of crystallins with lens plasma membrane fractions during cataract development could provide nucleation points for insolubilization of cytosolic proteins. Membrane fractions will be recovered with their full complement of extrinsic proteins. These proteins will be identified by SDS-PAGE, IEF and immunoblotting. 3. Fatty acid acylation of lens proteins could be a means for attachment of extrinsic proteins to the lens plasma membrane and could also participate in the control of lens cell proliferation and differentiation. The capacity of the intact lens and cultured lens epithelial cells to acylate membrane and cytoplasmic proteins with 3H-labeled fatty acids will be determined. Proteins will be identified by electrophoretic and immunological methods. The structure of the proteins will be studied by amino acid sequencing. 4. The link between inhibition of lens cholesterol synthesis and disorganization of lens membrane structure will be addressed by examining U18666A effects on the coordination of lens membrane synthesis. Increased exposure of hydrophobic domains of intrinsic proteins due to altered membrane structure could be the basis of the increased crystallin binding to cataractous membrane. The order of assembly of the molecular components of the fiber cell plasma membrane in control and U18666A exposed lenses will be determined by measuring the lens regional distribution of synthesis of the membrane's principal molecular components (cholesterol, phospholipid and MIP26) using 3H2O as substrate.

Agency
National Institute of Health (NIH)
Institute
National Eye Institute (NEI)
Type
Research Project (R01)
Project #
5R01EY002568-15
Application #
3256871
Study Section
Visual Sciences A Study Section (VISA)
Project Start
1978-08-01
Project End
1996-08-31
Budget Start
1992-09-01
Budget End
1993-08-31
Support Year
15
Fiscal Year
1992
Total Cost
Indirect Cost
Name
A.T. Still University of Health Sciences
Department
Type
Schools of Osteopathy
DUNS #
City
Kirksville
State
MO
Country
United States
Zip Code
63501
Cenedella, Richard J (2009) Cholesterol synthesis inhibitor U18666A and the role of sterol metabolism and trafficking in numerous pathophysiological processes. Lipids 44:477-87
Cenedella, Richard J; Sexton, Patricia S; Brako, Lawrence et al. (2007) Status of caveolin-1 in various membrane domains of the bovine lens. Exp Eye Res 85:473-81
Cenedella, Richard J; Neely, Amanda R; Sexton, Patricia (2006) Multiple forms of 22 kDa caveolin-1 alpha present in bovine lens cells could reflect variable palmitoylation. Exp Eye Res 82:229-35
Cenedella, Richard J; Sexton, Patricia S; Krishnan, Kathiresan et al. (2005) Comparison of effects of U18666A and enantiomeric U18666A on sterol synthesis and induction of apoptosis. Lipids 40:635-40
Cenedella, Richard J; Neely, Amanda R; Sexton, Patricia (2005) Concentration and distribution of ubiquinone (coenzyme Q), the endogenous lipid antioxidant, in the rat lens: effect of treatment with simvastatin. Mol Vis 11:594-602
Cenedella, Richard J; Jacob, Robert; Borchman, Douglas et al. (2004) Direct perturbation of lens membrane structure may contribute to cataracts caused by U18666A, an oxidosqualene cyclase inhibitor. J Lipid Res 45:1232-41
Sexton, Patricia S; Neely, Amanda R; Cenedella, Richard J (2004) Distribution of caveolin-1 in bovine lens and redistribution in cultured bovine lens epithelial cells upon confluence. Exp Eye Res 78:75-82
Cenedella, Richard J; Kuszak, Jerome R; Al-Ghoul, Kristin J et al. (2003) Discordant expression of the sterol pathway in lens underlies simvastatin-induced cataracts in Chbb: Thom rats. J Lipid Res 44:198-211
Cenedella, R J (2001) Specific labeling of lens aldehyde dehydrogenase class 1 from (3)H-cholesterol or its derivatives. Ophthalmic Res 33:210-6
Zhu, X L; Sexton, P S; Cenedella, R J (2001) Characterization of membrane steroid binding protein mRNA and protein in lens epithelial cells. Exp Eye Res 73:213-9

Showing the most recent 10 out of 49 publications